Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts

Hideki Nakasone, Kiriko Terasako-Saito, Rie Yamazaki, Miki Sato, Yukie Tanaka, Kana Sakamoto, Masakazu Kurita, Ryoko Yamasaki, Hidenori Wada, Yuko Ishihara, Koji Kawamura, Tomohito Machishima, Masahiro Ashizawa, Shun ichi Kimura, Misato Kikuchi, Aki Tanihara, Junya Kanda, Shinichi Kako, Junji Nishida, Shigeki YamadaYoshinobu Kanda

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Adiponectin has been shown to play a critical role in immunity. Recently, we reported that the adiponectin levels after allogeneic stem cell transplantation were higher in recipients with chronic graft-versus-host disease (cGVHD). However, the effects of adiponectin on extracellular matrix (ECM) and regulatory factors in dermal fibroblasts remain unclear. We compared the messenger RNA (mRNA) levels of collagen type1 (COL1A), fibronectin 1 (FN1), matrix metalloproteinase (MMP)1, MMP3, tissue inhibitor of metalloproteinase (TIMP)1, TIMP3, transforming growth factor-β (TGF-β), and TGF-β receptor 2 (TGF-βR2) in human normal dermal fibroblasts cultured with and without adiponectin, and we assessed the degree of synthesis of ECMs by immunofluorescent microscopy. Furthermore, we also assessed these mRNA levels after blocking of TGF-βR2. Adiponectin induced higher mRNA levels of FN1, MMP1, MMP3, TIMP1, TIMP3, and TGF-βR2 in a dose-dependent manner, but did not significantly affect COL1A or TGF-β. In addition, adiponectin was shown to upregulate FN1, MMPs, and TIMPs after blocking of TGF-βR2. Immunofluorescent microscopy revealed that adiponectin promoted a greater synthesis of ECMs than in the control invitro. The finding that adiponectin upregulated ECM-associated factors might mean that high levels of adiponectin could modulate dermal fibrosis was observed in recipients with cGVHD. Further basic investigation is warranted to elucidate whether the adiponectin-pathway could be a target for the treatment of sclerotic cGVHD.

Original languageEnglish
Pages (from-to)261-273
Number of pages13
JournalExperimental Hematology
Volume42
Issue number4
DOIs
Publication statusPublished - 2014 Jan 1
Externally publishedYes

Fingerprint

Adiponectin
Extracellular Matrix
Fibroblasts
Molecular Weight
Transforming Growth Factors
Skin
Graft vs Host Disease
Fibronectins
Tissue Inhibitor of Metalloproteinase-1
Messenger RNA
Microscopy
Matrix Metalloproteinase 1
Growth Factor Receptors
Stem Cell Transplantation
Matrix Metalloproteinases
Immunity
Fibrosis
Up-Regulation
Collagen

ASJC Scopus subject areas

  • Cancer Research
  • Cell Biology
  • Genetics
  • Molecular Biology
  • Hematology

Cite this

Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts. / Nakasone, Hideki; Terasako-Saito, Kiriko; Yamazaki, Rie; Sato, Miki; Tanaka, Yukie; Sakamoto, Kana; Kurita, Masakazu; Yamasaki, Ryoko; Wada, Hidenori; Ishihara, Yuko; Kawamura, Koji; Machishima, Tomohito; Ashizawa, Masahiro; Kimura, Shun ichi; Kikuchi, Misato; Tanihara, Aki; Kanda, Junya; Kako, Shinichi; Nishida, Junji; Yamada, Shigeki; Kanda, Yoshinobu.

In: Experimental Hematology, Vol. 42, No. 4, 01.01.2014, p. 261-273.

Research output: Contribution to journalArticle

Nakasone, H, Terasako-Saito, K, Yamazaki, R, Sato, M, Tanaka, Y, Sakamoto, K, Kurita, M, Yamasaki, R, Wada, H, Ishihara, Y, Kawamura, K, Machishima, T, Ashizawa, M, Kimura, SI, Kikuchi, M, Tanihara, A, Kanda, J, Kako, S, Nishida, J, Yamada, S & Kanda, Y 2014, 'Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts', Experimental Hematology, vol. 42, no. 4, pp. 261-273. https://doi.org/10.1016/j.exphem.2013.12.009
Nakasone, Hideki ; Terasako-Saito, Kiriko ; Yamazaki, Rie ; Sato, Miki ; Tanaka, Yukie ; Sakamoto, Kana ; Kurita, Masakazu ; Yamasaki, Ryoko ; Wada, Hidenori ; Ishihara, Yuko ; Kawamura, Koji ; Machishima, Tomohito ; Ashizawa, Masahiro ; Kimura, Shun ichi ; Kikuchi, Misato ; Tanihara, Aki ; Kanda, Junya ; Kako, Shinichi ; Nishida, Junji ; Yamada, Shigeki ; Kanda, Yoshinobu. / Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts. In: Experimental Hematology. 2014 ; Vol. 42, No. 4. pp. 261-273.
@article{284b469495354b7dbde54c88efa83e4b,
title = "Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts",
abstract = "Adiponectin has been shown to play a critical role in immunity. Recently, we reported that the adiponectin levels after allogeneic stem cell transplantation were higher in recipients with chronic graft-versus-host disease (cGVHD). However, the effects of adiponectin on extracellular matrix (ECM) and regulatory factors in dermal fibroblasts remain unclear. We compared the messenger RNA (mRNA) levels of collagen type1 (COL1A), fibronectin 1 (FN1), matrix metalloproteinase (MMP)1, MMP3, tissue inhibitor of metalloproteinase (TIMP)1, TIMP3, transforming growth factor-β (TGF-β), and TGF-β receptor 2 (TGF-βR2) in human normal dermal fibroblasts cultured with and without adiponectin, and we assessed the degree of synthesis of ECMs by immunofluorescent microscopy. Furthermore, we also assessed these mRNA levels after blocking of TGF-βR2. Adiponectin induced higher mRNA levels of FN1, MMP1, MMP3, TIMP1, TIMP3, and TGF-βR2 in a dose-dependent manner, but did not significantly affect COL1A or TGF-β. In addition, adiponectin was shown to upregulate FN1, MMPs, and TIMPs after blocking of TGF-βR2. Immunofluorescent microscopy revealed that adiponectin promoted a greater synthesis of ECMs than in the control invitro. The finding that adiponectin upregulated ECM-associated factors might mean that high levels of adiponectin could modulate dermal fibrosis was observed in recipients with cGVHD. Further basic investigation is warranted to elucidate whether the adiponectin-pathway could be a target for the treatment of sclerotic cGVHD.",
author = "Hideki Nakasone and Kiriko Terasako-Saito and Rie Yamazaki and Miki Sato and Yukie Tanaka and Kana Sakamoto and Masakazu Kurita and Ryoko Yamasaki and Hidenori Wada and Yuko Ishihara and Koji Kawamura and Tomohito Machishima and Masahiro Ashizawa and Kimura, {Shun ichi} and Misato Kikuchi and Aki Tanihara and Junya Kanda and Shinichi Kako and Junji Nishida and Shigeki Yamada and Yoshinobu Kanda",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.exphem.2013.12.009",
language = "English",
volume = "42",
pages = "261--273",
journal = "Experimental Hematology",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Impact of high-/middle-molecular-weight adiponectin on the synthesis and regulation of extracellular matrix in dermal fibroblasts

AU - Nakasone, Hideki

AU - Terasako-Saito, Kiriko

AU - Yamazaki, Rie

AU - Sato, Miki

AU - Tanaka, Yukie

AU - Sakamoto, Kana

AU - Kurita, Masakazu

AU - Yamasaki, Ryoko

AU - Wada, Hidenori

AU - Ishihara, Yuko

AU - Kawamura, Koji

AU - Machishima, Tomohito

AU - Ashizawa, Masahiro

AU - Kimura, Shun ichi

AU - Kikuchi, Misato

AU - Tanihara, Aki

AU - Kanda, Junya

AU - Kako, Shinichi

AU - Nishida, Junji

AU - Yamada, Shigeki

AU - Kanda, Yoshinobu

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Adiponectin has been shown to play a critical role in immunity. Recently, we reported that the adiponectin levels after allogeneic stem cell transplantation were higher in recipients with chronic graft-versus-host disease (cGVHD). However, the effects of adiponectin on extracellular matrix (ECM) and regulatory factors in dermal fibroblasts remain unclear. We compared the messenger RNA (mRNA) levels of collagen type1 (COL1A), fibronectin 1 (FN1), matrix metalloproteinase (MMP)1, MMP3, tissue inhibitor of metalloproteinase (TIMP)1, TIMP3, transforming growth factor-β (TGF-β), and TGF-β receptor 2 (TGF-βR2) in human normal dermal fibroblasts cultured with and without adiponectin, and we assessed the degree of synthesis of ECMs by immunofluorescent microscopy. Furthermore, we also assessed these mRNA levels after blocking of TGF-βR2. Adiponectin induced higher mRNA levels of FN1, MMP1, MMP3, TIMP1, TIMP3, and TGF-βR2 in a dose-dependent manner, but did not significantly affect COL1A or TGF-β. In addition, adiponectin was shown to upregulate FN1, MMPs, and TIMPs after blocking of TGF-βR2. Immunofluorescent microscopy revealed that adiponectin promoted a greater synthesis of ECMs than in the control invitro. The finding that adiponectin upregulated ECM-associated factors might mean that high levels of adiponectin could modulate dermal fibrosis was observed in recipients with cGVHD. Further basic investigation is warranted to elucidate whether the adiponectin-pathway could be a target for the treatment of sclerotic cGVHD.

AB - Adiponectin has been shown to play a critical role in immunity. Recently, we reported that the adiponectin levels after allogeneic stem cell transplantation were higher in recipients with chronic graft-versus-host disease (cGVHD). However, the effects of adiponectin on extracellular matrix (ECM) and regulatory factors in dermal fibroblasts remain unclear. We compared the messenger RNA (mRNA) levels of collagen type1 (COL1A), fibronectin 1 (FN1), matrix metalloproteinase (MMP)1, MMP3, tissue inhibitor of metalloproteinase (TIMP)1, TIMP3, transforming growth factor-β (TGF-β), and TGF-β receptor 2 (TGF-βR2) in human normal dermal fibroblasts cultured with and without adiponectin, and we assessed the degree of synthesis of ECMs by immunofluorescent microscopy. Furthermore, we also assessed these mRNA levels after blocking of TGF-βR2. Adiponectin induced higher mRNA levels of FN1, MMP1, MMP3, TIMP1, TIMP3, and TGF-βR2 in a dose-dependent manner, but did not significantly affect COL1A or TGF-β. In addition, adiponectin was shown to upregulate FN1, MMPs, and TIMPs after blocking of TGF-βR2. Immunofluorescent microscopy revealed that adiponectin promoted a greater synthesis of ECMs than in the control invitro. The finding that adiponectin upregulated ECM-associated factors might mean that high levels of adiponectin could modulate dermal fibrosis was observed in recipients with cGVHD. Further basic investigation is warranted to elucidate whether the adiponectin-pathway could be a target for the treatment of sclerotic cGVHD.

UR - http://www.scopus.com/inward/record.url?scp=84899087920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899087920&partnerID=8YFLogxK

U2 - 10.1016/j.exphem.2013.12.009

DO - 10.1016/j.exphem.2013.12.009

M3 - Article

C2 - 24407161

AN - SCOPUS:84899087920

VL - 42

SP - 261

EP - 273

JO - Experimental Hematology

JF - Experimental Hematology

SN - 0301-472X

IS - 4

ER -